Search Result "D2 PA"

D2 Receptor Partial Agonists: Treatment of CNS Disorders of Dopamine Function

Journal: Current Topics in Medicinal Chemistry
Volume: 8 Issue: 1 Year: 2008 Page: 1068-1088
Author(s): John H. Kehne, Terrance H. Andree, Julia N. Heinrich

Neurotensin NTS1-Dopamine D2 Receptor-Receptor Interactions in Putative Receptor Heteromers: Relevance for Parkinson`s Disease and Schizophrenia

Journal: Current Protein & Peptide Science
Volume: 15 Issue: 7 Year: 2014 Page: 681-690
Author(s): Luca Ferraro,Sarah Beggiato,Dasiel O. Borroto-Escuela,Laura Ravani,William T. O'Connor,Maria C. Tomasini,Andrea C. Borelli,Luigi F. Agnati,Tiziana Antonelli,Sergio Tanganelli,Kjell Fuxe

Relevance of Dopamine D2/Neurotensin NTS1 and NMDA/Neurotensin NTS1 Receptor Interaction in Psychiatric and Neurodegenerative Disorders

Journal: Current Medicinal Chemistry
Volume: 19 Issue: 3 Year: 2012 Page: 304-316
Author(s): S. Tanganelli, T. Antonelli, M. C. Tomasini, S. Beggiato, K. Fuxe, L. Ferraro

Novel Approaches in the Treatment of Antipsychotic-Induced Hyperprolactinemia:The Role of Partial Agonists of D2 Dopaminergic Receptors

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 4 Issue: 3 Year: 2010 Page: 230-240
Author(s): Domenico De Berardis, Tiziano Acciavatti, Daniela Campanella, Nicola Serroni, Luigi Olivieri, Carla Ranalli, Viviana Marasco, Alessandro Carano, Marilde Cavuto, Giuseppe Di Iorio, Monica Piersanti, Francesco S. Moschetta, Massimo Di Giannantonio

Dopamine Receptor Interacting Proteins: Targeting Neuronal Calcium Sensor-1/D2 Dopamine Receptor Interaction for Antipsychotic Drug Development

Journal: Current Drug Targets
Volume: 13 Issue: 1 Year: 2012 Page: 72-79
Author(s): Nadine Kabbani, Mathew P. Woll, Jacob C. Nordman, Robert Levenson

Treatment of Antipsychotic-Induced Hyperprolactinemia: An Update on the Role of the Dopaminergic Receptors D2 Partial Agonist Aripiprazole

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 8 Issue: 1 Year: 2014 Page: 30-37
Author(s): Domenico De Berardis,Michele Fornaro,Nicola Serroni,Stefano Marini,Monica Piersanti,Marilde Cavuto,Alessandro Valchera,Monica Mazza,Gabriella Girinelli,Felice Iasevoli,Giampaolo Perna,Giovanni Martinotti,Massimo Di Giannantonio

Conditioned Avoidance Response in the Development of New Antipsychotics

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 358-370
Author(s): M-L. G. Wadenberg

Current Strategies for the Development of Novel Antipsychotic Drugs

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 3 Issue: 3 Year: 2003 Page: 239-251
Author(s): Jordi Bolos

Antipsychotic Drugs: Evolving Mechanisms of Action with Improved Therapeutic Benefits

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 3 Issue: 3 Year: 2004 Page: 217-226
Author(s): B. Dean, E. Scarr

Novel Targets for Drugs in Schizophrenia

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 6 Issue: 4 Year: 2007 Page: 265-272
Author(s): J.M. Stone, L.S. Pilowsky

Previous   Next

Go To   Results 1 - 1 of 1864

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


© 2024 Bentham Science Publishers | Privacy Policy